TY  - GEN
AU  - Lv,Fang
AU  - Cai,Xiaoling
AU  - Ji,Linong
TI  - Response to "Denosumab and Romosozumab do not increase the risk of cardiovascular events in patients with primary osteoporosis: A reanalysis of the meta-analysis"
SN  - 1873-2763
PY  - 2020///1126
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Cardiovascular Diseases
KW  - epidemiology
KW  - Denosumab
KW  - Humans
KW  - Osteoporosis
KW  - drug therapy
N1  - Publication Type: Letter; Comment
UR  - https://doi.org/10.1016/j.bone.2020.115271
ER  -